Statins: new American guidelines for prevention of cardiovascular disease

被引：363

作者：

Ridker, Paul M. ^{[1
]}

Cook, Nancy R.

机构：

[1] Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Div Prevent Med, Boston, MA 02215 USA

来源：

LANCET | 2013年 / 382卷 / 9907期

关键词：

EVENTS; ROSUVASTATIN; TRIAL; ATORVASTATIN; CORONARY; AVERAGE; WOMEN; MEN;

D O I：

10.1016/S0140-6736(13)62388-0

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1762 / 1765

页数：4

共 15 条

[1] [Anonymous], 2013, J AM COLL CARDIOL, DOI DOI 10.1016/J.JACC.2013.11.005
[2] Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial
Colhoun, HM
Betteridge, DJ
Durrington, PN
Hitman, GA
Neil, HAW
Livingstone, SJ
Thomason, MJ
Mackness, MI
Charlton-Menys, V
Fuller, JH
[J]. LANCET, 2004, 364 (9435) : 685 - 696
[3] Use and misuse of the receiver operating characteristic curve in risk prediction
Cook, Nancy R.
[J]. CIRCULATION, 2007, 115 (07) : 928 - 935
[4] Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels - Results of AFCAPS/TexCAPS
Downs, JR
Clearfield, M
Weis, S
Whitney, E
Shapiro, DR
Beere, PA
Langendorfer, A
Stein, EA
Kruyer, W
Gotto, AM
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (20): : 1615 - 1622
[5] Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis
Fellstroem, Bengt C.
Jardine, Alan G.
Schmieder, Roland E.
Holdaas, Hallvard
Bannister, Kym
Beutler, Jaap
Chae, Dong-Wan
Chevaile, Alejandro
Cobbe, Stuart M.
Groenhagen-Riska, Carola
De Lima, Jose J.
Lins, Robert
Mayer, Gert
McMahon, Alan W.
Parving, Hans-Henrik
Remuzzi, Giuseppe
Samuelsson, Ola
Sonkodi, Sandor
Sueleymanlar, Gultekin
Tsakiris, Dimitrios
Tesar, Vladimir
Todorov, Vasil
Wiecek, Andrzej
Wuethrich, Rudolf P.
Gottlow, Mattis
Johnsson, Eva
Zannad, Faiez
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (14) : 1395 - 1407
[6] FINAL REPORT ON THE ASPIRIN COMPONENT OF THE ONGOING PHYSICIANS HEALTH STUDY
HENNEKENS, CH
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (03) : 129 - 135
[7] Rosuvastatin in older patients with systolic heart failure
Kjekshus, John
Apetrei, Eduard
Barrios, Vivencio
Boehm, Michael
Cleland, John G. F.
Cornel, Jan H.
Dunselman, Peter
Fonseca, Candida
Goudev, Assen
Grande, Peer
Gullestad, Lars
Hjalmarson, Ake
Hradec, Jaromir
Janosi, Andras
Kamensky, Gabriel
Komajda, Michel
Korewicki, Jerzy
Kuusi, Timo
Mach, Francois
Mareev, Vyacheslav
McMurray, John J. V.
Ranjith, Naresh
Schaufelberger, Maria
Vanhaecke, Johan
van Veldhuisen, Dirk J.
Waagstein, Finn
Wedel, Hans
Wikstrand, John
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (22) : 2248 - 2261
[8] The Women's Health Initiative Observational Study: Baseline characteristics of participants and reliability of baseline measures
Langer, RD
White, E
Lewis, CE
Kotchen, JM
Hendrix, SL
Trevisan, M
[J]. ANNALS OF EPIDEMIOLOGY, 2003, 13 (09) : S107 - S121
[9] Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial
Nakamura, Haruo
Arakawa, Kikuo
Itakura, Hiroshige
Kitabatake, Akira
Goto, Yoshio
Toyota, Takayoshi
Nakaya, Noriaki
Nishimoto, Shoji
Muranaka, Masaharu
Yamamoto, Akira
Mizuno, Kyoichi
Ohashi, Yasuo
[J]. LANCET, 2006, 368 (9542) : 1155 - 1163
[10] Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Ridker, Paul M.
Danielson, Eleanor
Fonseca, Francisco A. H.
Genest, Jacques
Gotto, Antonio M., Jr.
Kastelein, John J. P.
Koenig, Wolfgang
Libby, Peter
Lorenzatti, Alberto J.
MacFadyen, Jean G.
Nordestgaard, Borge G.
Shepherd, James
Willerson, James T.
Glynn, Robert J.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (21) : 2195 - 2207

← 1 2 →